Burning Rock Biotech (BNR) Free Cash Flow (2019 - 2025)

Burning Rock Biotech's Free Cash Flow history runs 7 years deep, the most recent figure standing at $3.3 million for Q4 2025.

• In Q4 2025, Free Cash Flow rose 26.12% year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at -$7.0 million (up 76.56% YoY), while the FY2025 annual figure was -$4.7 million, up 64.55% from the prior year.
• Free Cash Flow was $3.3 million for Q4 2025 at Burning Rock Biotech, up from $2.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $3.3 million in Q4 2025 to a low of -$22.7 million in Q1 2022.
• Historically, Free Cash Flow has averaged -$10.8 million across 5 years, with a median of -$11.3 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Free Cash Flow plunged 1632.5% in 2021, then soared 215.74% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$17.6 million in 2021, then soared by 46.0% to -$9.5 million in 2022, then soared by 76.3% to -$2.3 million in 2023, then jumped by 215.74% to $2.6 million in 2024, then gained by 26.12% to $3.3 million in 2025.
• The last three Free Cash Flow figures came in at $3.3 million (Q4 2025), $2.3 million (Q3 2025), and -$9.4 million (Q2 2025), per Business Quant data.